Date published: 2026-5-19

1-800-457-3801

SCBT Portrait Logo
Seach Input

L-Malate Dehydrogenase Activators

L-Malate Dehydrogenase (MDH) is an enzyme of significant importance in the metabolic pathways of cells, serving a critical function in the citric acid cycle. This enzyme catalyzes the interconversion of L-malate to oxaloacetate while concurrently converting NAD+ to NADH, or vice versa. This reaction is integral for the production of energy within the cell and is essential for numerous biosynthetic processes. MDH is an enzyme that is ubiquitously expressed across various tissues, reflecting its fundamental role in cellular metabolism. The enzyme exists in two isoforms, each targeted to a different cellular compartment; one is localized within the mitochondria, playing a direct role in the citric acid cycle, and the other is found in the cytoplasm, where it's implicated in the malate-aspartate shuttle, a crucial mechanism for transferring reducing equivalents across the mitochondrial membrane.

Several chemical compounds have been identified that can potentially induce the expression of L-Malate Dehydrogenase, acting as activators of its genetic transcription. Retinoic acid, for example, is known to be a potent inducer of gene expression through its interaction with retinoic acid receptors, potentially upregulating MDH in processes that require increased metabolic activity. Similarly, thyroid hormones like 3,3',5-Triiodo-L-thyronine (T3) can escalate the basal metabolic rate, possibly necessitating an elevation in MDH levels to support heightened metabolic demands. Other compounds, such as dexamethasone, a glucocorticoid, are implicated in the upregulation of genes central to metabolic homeostasis and could lead to an increased synthesis of MDH to maintain energy balance within the cell. Metabolic regulators like metformin and phenformin, which activate AMP-activated protein kinase (AMPK), suggest a potential role in stimulating the pathways generating ATP, including the possible upregulation of MDH to adapt to energy requirements. Lastly, resveratrol, a polyphenolic compound, has been shown to activate sirtuins and AMPK, indicating a stimulatory effect on metabolic pathways that may include the induction of MDH expression. These activators, by potentially upregulating MDH, contribute to the fine-tuning of energy production and metabolic balance in cells, highlighting the interconnectedness of metabolic regulation and enzyme expression.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

Retinoic acid can initiate transcriptional activation of genes by binding to retinoic acid receptors, which may upregulate MDH as part of a coordinated response to cellular differentiation and metabolism.

L-3,3′,5-Triiodothyronine, free acid

6893-02-3sc-204035
sc-204035A
sc-204035B
10 mg
100 mg
250 mg
$41.00
$77.00
$153.00
(1)

As an active thyroid hormone, T3 can stimulate the expression of genes governing basal metabolic rate, including potentially increasing MDH levels to meet elevated metabolic demands.

Dexamethasone

50-02-2sc-29059
sc-29059B
sc-29059A
100 mg
1 g
5 g
$91.00
$139.00
$374.00
36
(1)

Dexamethasone can stimulate the transcriptional activity of genes involved in anti-inflammatory responses and metabolism, potentially leading to increased MDH synthesis for enhanced metabolic homeostasis.

Metformin

657-24-9sc-507370
10 mg
$79.00
2
(0)

Metformin activates AMPK, leading to the stimulation of catabolic pathways that generate ATP, which could include the upregulation of MDH as part of the cellular adaptation to energy stress.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

Resveratrol has been shown to activate sirtuins and AMPK, leading to the stimulation of metabolic pathways that combat oxidative stress and may induce the expression of MDH for better metabolic efficiency.